CalciMedica, Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/97c30c82-3b99-4a4a-926d-23b28ab314a5/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-23.1M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-088147 |
| FY 2024 | $-24.2M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-046035 |
| FY 2023 | $-38.1M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-038064 |
| FY 2022 | $-14.2M | 2022-01-01 – 2022-12-31 | evidence 0000950170-24-038064 |
| FY 2021 | $-35.9M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-009728 |
| FY 2020 | $-29.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-011305 |
| FY 2019 | $-37.5M | 2019-01-01 – 2019-12-31 | evidence 0001564590-21-011305 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).